• Cardiome Pharma Corp. (COM.TO) to Axe 85 Pct. of Jobs More...

• Renaissance Pharma Will Not Cut DPT Laboratories, Ltd. Jobs More...

• Audeo Oncology Files for $60 Million IPO More...

• Biolex Therapeutics Execs Gone Before Filing for $38 Million Bankruptcy More...

• GenKyoTex S.A. Raises $26 Million for Phase II Development of Diabetic Nephropathy Drug More...

• Imperial Innovations Leads $34 Million Funding Round for PsiOxus Therapeutics Limited More...

• Will Johnson & Johnson (JNJ) Bid for the Rest of Elan Corporation PLC (ELN)? More...

• Will Celgene (CELG) Bid for Human Genome Sciences, Inc. (HGSI)? More...

• AptarGroup Completes Acquisition of Stelmi Group; Updates Second Quarter Earnings Guidance and Sets Second Quarter Earnings Release and Conference Call Dates More...

• BioRx Acquires Coagulife Pharmacy More...

• FEI Company Buys the Assets of Its Korean Agent More...

• Pfizer Inc. (PFE) Licenses Diabetes Drug to Russia's SatRx More...

• Sucampo Pharmaceuticals, Inc. Falls After Failing to End Drug Deal With Takeda Pharmaceutical Co. Ltd. (TKDG.DE) More...

• PDS Biotechnology Corporation Signs Worldwide Licensing Agreement With Merck KGaA (MKGAF.PK) for Versamune™ More...

• ChemDiv Research Institute Announces R&D Collaborations With Abbott Laboratories (ABT) in Russia More...

• Medicyte GmbH and Reinnervate Limited to Collaborate on Development of Next Generation Predictive 3D Cell Toxicity Assays More...

• Ceapro Inc. (CV:CZO) Announces Re-Election of Board, Adoption of Amended Stock Option Plan and Appointment of President and CEO More...

• FGTB Holdings Names CEO More...

• Affymax, Inc. (AFFY) Promotes Michael Holfinger, Ph.D., to Vice President, Manufacturing and CMC Development More...

• CRF Health Appoints Mark Maietta, MBA as Senior Vice President of Global Business Development More...

• Onyx Pharmaceuticals, Inc. (ONXX) Names John E. Osborn Senior Vice President, Global Corporate Affairs More...

• Akorn, Inc. (AKN) Announces Second Quarter 2012 Earnings Release And Conference Call Information More...

• Allergan Inc. (AGN) Announces Quarterly Conference Call More...

• Dr. Reddy's Laboratories Ltd. (RDY)'s to Release Q1 FY13 Results on July 19, 2012 More...

• Emergent BioSolutions (EBS) to Release Second Quarter 2012 Financial Results and Conduct a Conference Call on August 2, 2012 More...

• Florence Pharma Multan and Cann Pharmaceutical CEO's Detained More...

• Bayer AG (BAY.F), Johnson & Johnson (JNJ)'s Xarelto Wins FDA Priority Review More...

• Acusphere Inc. (ACUS) Announces Completion of Marketing Authorisation Application for Imagify™ in Europe; Secures Additional Financing More...

• Capricor Announces FDA Approval to Initiate ALLSTAR Trial of Allogeneic Stem Cell Therapy in Patients Following Heart Attack More...

• FDA Approves QIAGEN N.V. (QGEN) KRAS Test for Use With Eli Lilly and Company (LLY) and Bristol-Myers Squibb Company (BMY)'s Cancer Drug Erbitux More...

• Auxilium Pharmaceuticals (AUXL) and Actelion Pharmaceuticals US, Inc. (ATLN.VX) Announce Approval of XIAFLEX® In Canada More...

• Senomyx, Inc. (SNMX) Announces Regulatory Approvals for S6973, S2383, S6821, And S7958 In Many International Markets More...

• Isotechnika Pharma Inc. (ISA.TO)'s Partner Lux Biosciences Completes Enrollment in Phase 3 Uveitis Study More...

• FDA Accepts Repros Therapeutics Inc. (RPRX)' Phase 3 Efficacy Protocol for Androxal® Under a Special Protocol Assessment Agreement More...

• Bayer HealthCare (BAY) Initiates Phase II/III Trial of New Recombinant Factor VIII Compound for Treatment of Hemophilia A More...

• Inspiration Biopharmaceuticals Reports Positive Interim Results from the Accur8 Phase 2/3 Study of OBI-1 in Acquired Hemophilia A at World Federation of Hemophilia 2012 World Congress More...

• Verona Pharma Initiates Dosing in Clinical Trial to Investigate Anti-inflammatory Properties of RPL554 More...

• Sunburn May Help Rid Body of Radiation-Damaged Cells, University of California, San Diego (UCSD) Study More...

• Babies in Dog-Owning Families May Be Healthier, Kuopio University Hospital Study More...

• New Drug Offers New Hope for MS Patients, University Hospital in Basel Study More...

• Why Women Watch the Olympics, University of Tennessee Study More...

• Advanced Cell Technology Secures Approval to Proceed with Increased RPE Dosage for Patients in Clinical Trial for Dry AMD More...

• Novartis AG (NVS) India Patent Case Postponed to August 22 More...

• CytRx Corporation (CYTR) Announces Allowance of U.S. Patent Application for Tamibarotene Capsule More...

• Organovo Announces Two Issued Patents, First Company Patent and Key Founder Patent More...

• Chinese and Australian Patents Allowed for 22nd Century Group, Inc.'s NBB Nicotine Biosynthesis Gene More...

• AtheroNova Receives Notice of Allowance for Its US Patent Application 12/024,908 More...

• Mobius Theraputics™ Commences First Shipments of New Glaucoma Drug More...

• Aceto Corporation Subsidiary, Rising Pharmaceuticals, Inc, Launches Generic Version of Soma® Compound With Aspirin Tablets and Sodium Bicarbonate Tablets More...

• Astellas Pharma Inc. (YPH.BE) and XenoPort, Inc. (XNPT) Announce the Launch of Regnite® Tablets for Restless Legs Syndrome in Japan More...